| Name | Title | Contact Details |
|---|---|---|
Solomon Rubinfeld |
Chief Operating Officer of SNF Division | Profile |
Instromedix is a Rosemont, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In a rapidly changing industry, caregivers remain the constant. Every day they demonstrate their passion for helping people despite unprecedented pressure to increase access and quality of care with the same or fewer resources. Hillrom is driven by patient-centered care. Everything we do, and all our products and technologies, are designed to enhance outcomes for patients and caregivers. It starts with cutting through complexity and focusing on the human side of healthcare. By continuously advancing and integrating our solutions, we enable clinicians to be vitally connected to their patients by delivering timely data and actionable insights. That means more accurate diagnoses, earlier intervention and faster recovery times. Our innovations put more heart in healthcare. Through more intelligent—and more connected—solutions, we help simplify routine workflows and communication, enabling care teams to focus on their passion—helping patients get better sooner. And we continuously raise the bar on quality and safety, building upon our legacy of trust with providers around the world. As healthcare continues to evolve, we`re here to support the people at the heart of it. Hillrom. Advancing Connected Care™.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.
Baxa sub Baxter International is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IDEX Health & Science is the global authority in fluidics and optics` bringing life to advanced optofluidic technologies with our products` people and engineering expertise. We are respected worldwide for solving complex problems and delivering complete path innovation for analytical` diagnostic and biotechnology applications for the life sciences market. As a genuine and trustworthy partner` we solve our customers’ most demanding challenges with the industry`s most extensive portfolio of state-of-the-art components and capabilities that are unrivaled in breadth` quality` performance and design. Our vision of the complete path goes far beyond just meeting our customers’ needs — it anticipates them` with intelligent solutions for life.